New Nordic Healthbrands AB

Total Valuation

New Nordic Healthbrands AB carries a market capitalization of 76.82M, placing it among publicly traded companies globally. Its enterprise value stands at 148.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

New Nordic Healthbrands AB currently has 6.20M shares outstanding.

Valuation Ratios

New Nordic Healthbrands AB trades at a trailing price-to-earnings ratio of 24.40. The price-to-sales ratio is 0.21, and the price-to-book ratio stands at 19.50.

Enterprise Valuation

On an enterprise value basis, New Nordic Healthbrands AB trades at an EV/EBITDA multiple of 14.99 and an EV/FCF ratio of 10.50. The EV/Sales ratio of 0.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.99 provides insight into valuation relative to core operating earnings.

Financial Position

New Nordic Healthbrands AB maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.93, indicating elevated leverage, while an interest coverage ratio of 3.43 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

New Nordic Healthbrands AB posts a return on equity of 9.77 and a return on invested capital of 4.67.

Taxes

Over the trailing twelve months, New Nordic Healthbrands AB has paid 2.35M in income taxes, reflecting an effective tax rate of 32.22.

Stock Price Statistics

New Nordic Healthbrands AB's stock has declined approximately -35.41667% over the past 52 weeks. The 50-day moving average sits at 14.62, while the 200-day moving average is 18.89.

Income Statement

Over the trailing twelve months, New Nordic Healthbrands AB generated 566.00M in revenue and converted that into 4.95M in net income, yielding earnings per share of 0.80. EBITDA reached 9.93M, while operating income came in at 9.93M.

Balance Sheet

New Nordic Healthbrands AB holds 9.69M in cash and equivalents against 37.72M in total debt, resulting in a net debt position of 28.03M. Total book value stands at 6.20M, with working capital of 83.18M providing operational flexibility.

Cash Flow

New Nordic Healthbrands AB produced 7.56M in operating cash flow over the past twelve months. After subtracting -4.65M in capital expenditures, free cash flow totaled 2.90M - equivalent to 0.47 per share.

Margins

New Nordic Healthbrands AB operates with a gross margin of 64.58, reflecting its pricing power and cost economics. The operating margin of 1.75 and net profit margin of 0.87 provide insight into operational efficiency.

Dividends & Yields

Scores

New Nordic Healthbrands AB posts an Altman Z-Score of 3.31, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.